[1] HU Z,FAN C,OH D S,et al.The molecular portraits of breast tumors are conserved across microarray platforms[J].BMC Genomics,2006,(7):96.
[2] BERTUCCI F,FINETTI P,CERVERA N,et al.How basal are triple-negative breast cancers? [J].Int J Cancer,2008,123(1):236-240.
[3] WILLIAM J,IRVIN Jr,LISA A.What is triple-negative breast cancer? [J].Eur J Cancer,2008,44(18):2799-2805.
[4] DIALLO-DANEBROCK R,TING E,GLUZ O,et al.Prognostic and predictive impact of protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy[J].Clin Cancer Res,2007,13(2):488-497.
[5] CAREY L A,PEROU C M,LIVASY C A,et al.Race,breast cancer subtypes,and survival in the Carolina breast cancer study[J].JAMA,2006,295(21):2492-2502.
[6] DIALLO-DANEBROCK R,TING E,GLUZ O,et al.Prognostic and predictive impact of protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy[J].Clin Cancer Res,2007,13(2):488-497.
[7] BAUER K R,BROWN M,CRESS R D,et al.Descriptive analysis of estrogen receptor(ER)-negative,progesterone receptor(PR)-negative,and HER2-negative invasive breast cancer,the so-called triple-negative phenotype:a population-based study from the California Cancer Registry[J].Cance,2007,109(9):1721-1728.
[8] MINUCCI S,PELICEI P G.Histone deacetylase inhibitors and the promise of epigenetic(and more) treatments for cancer[J].Nat Rev Cancer,2006,6(1):38-51.
[9] 尹子卉,吴仲闻,兰玉坤,等.新型抗肿瘤组蛋白去乙酰化酶抑制剂西达本胺的合成[J].中国新药杂志,2004,13(6):536-538.
[10] 郑杰.肿瘤的细胞与分子生物学[M].上海:上海科学技术出版社,2011:249-251.
[11] 陈佳,周武庆,陈浩,等.西达本胺对恶性黑色素瘤细胞系A375的体外抗增殖作用[J].中华皮肤科杂志,2009,42(4):255-258.
[12] 程宏,王璇琳,赵丽晶,等.西达本胺对人前列腺癌DU145及PC3细胞凋亡的影响[J].生物技术通讯,2012,10(4):176-179.
[13] 何向明,李苏宜,刘琳,等.西达本胺对结肠癌LoVo细胞增殖抑制的体外研究[J].肿瘤学杂志,2009,15(4):310-313.
[14] 李艳莹,王艳芳.西达本胺对人B淋巴细胞株的作用及其机制研究[J].中国实验血液学杂志,2012,20(4):893-899.
[15] 周珊,姜藻,顾晓怡.西达本胺对胃癌SGC-7901细胞增殖、凋亡及Notch1、Sirt1基因表达的影响研究[J].东南大学学报:医学版,2012,31(3):273-276.
[16] NING Z Q,LI Z B,NEWMAN M J,et al.Chidamide(CSO55/HBI-8000):a new histone deacetylase inhibitor of yhe benzamide class with antitumor activity and the ability to enhance immune cell-mediated humor cell cytotoxicity[J].Cancer Chemother Pharmacol,2012,69(4):901-909.
[17] LIU L,CHEN B,QIN S,et al.Anover histone deacetylase inhibitor chidamide induse apoptosis of hum colou cancer cells[J].Biochem Biophys Commun,2010,292(2):190-195.
[18] ALTAHA R,IAANG X,YU J J,et al.Excision repair cross complementing—group1:gene expression and platinum resistance [J].Int J Mol Med,2004,14:959-970.
[19] 成红艳,陈宝安,孙新臣,等,ERCC1、XRCC1单核苷酸多态性与非小细胞肺癌铂类药物化疗预后关系的研究[J].东南大学学报:医学版,2011,30(5):717-721.
[20] EBPG Expert Group on Renal Transplantation.European best practice guidelines for renal transplantation[J].Nephrol Dial Transplant,2002,17(4):34-39. |